HOME >> BIOLOGY >> NEWS
Federal testing for mad cow disease a failure, law review editor says

gency and the beef industry from a public outcry that would take place if more cases of mad cow disease were found. "In its 93 years of existence, the Virus-Serum-Toxin Act has never been used or interpreted to regulate testing of any kind. Manipulating the act to include the BSE test perverts the statute's purpose."

Congress should pass legislation forcing the USDA to license BSE tests to ranchers and slaughterhouses. "The USDA should create standards for testing conditions and requirements, and promulgate an application process with objective criteria for private producers. A standard testing regime would enable private producers such as Creekstone to market their beef as 'tested for BSE.'"

Berlowitz cited news reports that the cost of such testing would add only 6 to 10 cents to a pound of beef.

His article further warns of poor oversight of cattle feed. In particular, the slaughterhouse practice of "rendering," or recycling dead cows and sheep into protein for cattle feed, is believed to be widespread.

Congress banned the practice in 1997 following evidence that feeding herbivorous cows the meat from dead animals can lead to the formation of abnormal proteins, or prions.

The prions attack a cow's brain tissue, causing holes to form. As the brain loses function, the cow becomes disoriented and clumsy. Eventually the animal loses all muscle control and is unable to walk or eat. No treatment is available.

Enforcement of cattle-feed restrictions was placed in the hands of the Food and Drug Administration (FDA) rather than the USDA, which has caused various bureaucratic snarls, including a lack of communication between the two agencies.

"The FDA is far behind on inspecting feed businesses subject to the feed ban, has no uniform plan to identify feed businesses, has no routine procedure for testing of cattle feed, does not require a notice about the ban to be placed on feed, and has repeatedly failed to noti
'"/>

Contact: Mark Reutter, Business & Law Editor
mreutter@uiuc.edu
217-333-0568
University of Illinois at Urbana-Champaign
15-May-2006


Page: 1 2 3 4

Related biology news :

1. SNM opposes new payment caps on imaging services detailed in Federal Deficit Reduction Act
2. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
3. ORNL technologies win maximum Federal Laboratory Consortium awards
4. Federal/private partners launch resource for diabetic kidney disease gene studies
5. Modular leukemia drug shows promise in early testing
6. Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths
7. XDx to present recent success with AlloMap molecular expression testing
8. Potential genetic testing for substance abuse raises hope, concern
9. U-M team: Genetic testing sheds light on degenerative eye disease
10. Antiretroviral resistance testing in HIV infected patients improves health and saves costs
11. Professors to develop hand-held pathogen testing device

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Federal testing for mad cow disease failure law review editor says

(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
(Date:4/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9pknhj/complete_201516 ... "Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry ... Stem cell research and experimentation have been in ... cells have the unique ability to divide and ... them to differentiate into a wide variety of ...
(Date:4/21/2015)... , April 21, 2015  Scientists from the ... research organization, published a paper today outlining new ... microalgae called diatoms. The researchers, led by first ... author Philip Weyman , Ph.D., conclude that ... understanding of diatom genetics and thus facilitate advances ...
(Date:4/21/2015)... April 21, 2015 Ampio Pharmaceuticals, Inc. (NYSE ... investor call on Thursday, April 23, 4:30 p.m. ET. ... as follows: Investor call information: ... 789-4877 International toll number: (925) 418-7845 Participant Passcode: 32888538 ... Tina Amirkiai , tina.amirkiai@fleishman.com . ...
(Date:4/21/2015)... 2015  scPharmaceuticals, Inc., a privately held ... subcutaneous delivery, announced today that it has ... proprietary drug product, Furosemide Injection Solution, for ... heart failure. Concurrently with its ... patch pump.  The patch pump is designed ...
Breaking Biology Technology:Global Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 3
Cached News: